This indicates that single methylation marker analysis of ASCL1 or LHX8 would be an interesting primary cervical screening tool in WLHIV in low‐resource settings, as it detects the majority of CIN3 lesions that need treatment and provides a high reassurance against cervical cancer. Here, LHX8 is linked to cervical cancer.